Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology


  1. 2022
  2. Published

    Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

    Loft, Mathias Hougaard, Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Otorai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Journal of Neuroendocrinology. 34, S1, p. 151-151 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Published

    Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.

    Loft, M., Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Oturai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Molecular Imaging and Biology. 24, p. 600–611

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, p. 1871-1879

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Phase II study of everolimus and temozolomide as 1-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms (NET G3 and NEC)

    Morken, S., Langer, Seppo W., Sundlov, A., Detlefsen, S., Krogh, M., Tabaksblat, E., Hjortland, G. O., Svensson, J. B., Assmus, J., Couvelard, A., Perren, A. & Sorbye, H., 2022, In: Journal of Neuroendocrinology. 34, S1, p. 181-181 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  6. Published

    Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

    Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & 7 others, Homann, P. H., Kristensen, E. B., Drivsholm, L. B., Bøgsted, M., Christensen, H. S., Pøhl, M. & Bjørnhart, B., 2022, In: Acta Oncologica. 61, 4, p. 409-416

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer

    Ryssel, Heidi, Egebjerg, K., Nielsen, Susanne Dam, Lundgren, Jens, Pøhl, M., Langer, Seppo W., Kjær, Andreas, Ostrowski, Sisse Rye & Fischer, Barbara Malene Bjerregaard, 2022, In: Frontiers in Immunology. 13, p. 1-12 1024224.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinoma

    Soldath, Patrick, Binderup, Tina, Carstensen, F., Clausen, Malene Martini, Kjær, Andreas, Federspiel, B., Knigge, Ulrich, Langer, Seppo W. & Petersen, René Horsleben, 2022, In: Surgical Oncology. 41, 101728.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Stereotactic radiosurgery of brain metastases in large cell neuroendocrine carcinoma of the lung

    Suppli, M. H., Langer, Seppo W., Persson, Gitte F. & Moller, S., 2022, In: Journal of Neuroendocrinology. 34, S1, p. 207-207 1 p., J17.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. 2021
  11. Published

    18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients

    Binderup, Tina, Knigge, U., Johnbeck, C. B., Loft, A., Berthelsen, A. K., Oturai, P., Mortensen, Jann, Federspiel, B., Langer, Seppo W. & Kjær, Andreas, 2021, In: The Journal of Nuclear Medicine. 62, 6, p. 808-815 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 TAHOE Study

    Blackhall, F., Jao, K., Greillier, L., Cho, B. C., Penkov, K., Reguart, N., Majem, M., Nackaerts, K., Syrigos, K., Hansen, K., Schuette, W., Cetnar, J., Cappuzzo, F., Okamoto, I., Erman, M., Langer, S. W., Kato, T., Groen, H., Sun, Z., Luo, Y. & 4 others, Tanwani, P., Caffrey, L., Komarnitsky, P. & Reinmuth, N., 2021, In: Journal of Thoracic Oncology. 16, 9, p. 1547-1558

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 33841728